Related Experiment Video

Updated: Jun 5, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines

L Bastin-Coyette1, S Cardoen, C Smal

  • 1Laboratory of Physiological Chemistry, de Duve Institute and Université catholique de Louvain, B-1200 Brussels, Belgium.

Biochemical Pharmacology
|December 21, 2010
PubMed

Insights

Nucleoside analogs (NAs) reduce p21 protein levels in chronic lymphocytic leukemia (CLL) cells, despite p53 activation. This unexpected p21 depletion promotes cell cycle progression, revealing an alternative cellular response to these anticancer agents.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Signaling

Background:

  • Nucleoside analogs (NAs) are anticancer agents that trigger cell death, often via p53 activation and apoptosis.
  • Typically, p53 activation leads to p21 accumulation and cell cycle arrest.
  • Previous studies noted 2-chloro-2'-deoxyadenosine (CdA) promotes G1/S transition in chronic lymphocytic leukemia (CLL) cells.

Purpose of the Study:

  • To investigate the p21 response to nucleoside analogs (NAs) in chronic lymphocytic leukemia (CLL) cells.
  • To elucidate the mechanism behind the observed G1/S transition promotion by NAs.

Main Methods:

  • Treatment of CLL cell lines (EHEB, JVM-2) with various NAs (CdA, fludarabine, gemcitabine, cytarabine).
  • Analysis of p53 and p21 protein and mRNA levels.
  • Assessment of proteasomal degradation, cyclin-dependent kinase 2 (Cdk2) activity, and proliferating cell nuclear antigen (PCNA) ubiquitination.
  • Comparison with other p53 activators (etoposide, nutlin-3a).

Main Results:

  • NAs significantly reduced p21 protein levels in CLL cells, despite p53 induction and increased p21 mRNA.
  • This p21 depletion was mediated by proteasomal degradation and was ubiquitin-independent.
  • NAs increased Cdk2 activity and PCNA monoubiquitination, processes normally inhibited by p21.

Conclusions:

  • Nucleoside analogs induce an alternative cellular response in certain cancer models by reducing p21 protein levels.
  • This mechanism bypasses the classical p21-mediated cell cycle arrest, promoting cell proliferation.
  • Findings challenge the conventional understanding of NA-induced cell cycle regulation in CLL.

More Related Videos

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation09:09

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...